General health checks in adults for reducing morbidity and mortality from disease

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 1, 2019, Pages

  Krogsbøll, Lasse T ^a   Jørgensen, Karsten Juhl ^a   Gøtzsche, Peter C ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL OUTCOME; DISABILITY; EVIDENCE BASED MEDICINE; GENERAL PRACTITIONER; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL EXAMINATION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PATIENT WORRY; PATIENT-REPORTED OUTCOME; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SCREENING TEST; SYSTEMATIC REVIEW; CAUSE OF DEATH; DIAGNOSIS; DISEASES; HEALTH PROMOTION; META ANALYSIS; PRIMARY PREVENTION; PROCEDURES;

ADULT; CAUSE OF DEATH; DIAGNOSIS; DISEASE; HEALTH PROMOTION; HUMANS; MORBIDITY; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84872970578     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009009.pub3     Document Type: Review

References (202)

1. Skaaby T, Jørgensen T, Linneberg A. Effects of invitation to participate in health surveys on the incidence of cardiovascular disease: a randomized general population study. International Journal of Epidemiology 2017;46(2):603-11. 9933735
2. Christensen B, Engberg M, Lauritzen T. No long-term psychological reaction to information about increased risk of coronary heart disease in general practice. European Journal of Cardiovascular Prevention and Rehabilitation 2004;11(3):239-43. 2835664
3. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. Can systematic general health screening and patient-physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5-year follow-up [Kan systematiske generelle helbredsundersøgelser og helbredssamtaler forbedre den kardiovaskulære risikoprofil i befolkningen? En randomiseret og kontrolleret undersøgelse i almen praksis med fem års opfølgning]. Ugeskrift for Laeger 2002;164(25):3354-60. 2835665
4. Engberg M, Christensen B, Karlsmose B, Lous J, Lauritzen T. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. The Journal of Family Practice 2002;51(6):546-52. 2835666
5. Geest TA, Engberg M, Lauritzen T. Discordance between self-evaluated health and doctor-evaluated health in relation to general health promotion. Scandinavian Journal of Primary Health Care 2004;22(3):146-51. 2835667
6. Kanstrup H, Refsgaard J, Engberg M, Lassen JF, Larsen ML, Lauritzen T. Cholesterol reduction following health screening in general practice. Scandinavian Journal of Primary Health Care 2002;20(4):219-23. 2835668
7. Karlsmose B, Lauritzen T, Engberg M, Parving A. A randomised controlled trial of screening for adult hearing loss during preventive health checks. The British Journal of General Practice 2001;51(466):351-5. 2835669
8. Larsen EL, Thomsen JL, Lauritzen T, Engberg M. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis - en analyse af patientperspektivet. En analyse med særligt fokus på Sundhedsprojekt Ebeltoft og andre randomiserede studier]. Medicinsk Teknologivurdering - puljeprojekter 6(7). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering 2006. 2835670
9. Lauritzen T. [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte-kar-sygdom]. Månedsskrift for Almen Praksis 2012;90(3):245-50. 2835674
10. Lauritzen T, Jensen MS, Thomsen JL, Christensen B, Engberg M. Health tests and health consultations reduced cardiovascular risk without psychological strain, increased healthcare utilization or increased costs. An overview of the results from a 5-year randomized trial in primary care. The Ebeltoft Health Promotion Project (EHPP). Scandinavian Journal of Public Health 2008;36(6):650-61. 2835671
11. Lauritzen T, Leboeuf-Yde C, Lunde IM, Nielsen KD. Ebeltoft project: baseline data from a five-year randomized, controlled, prospective health promotion study in a Danish population. The British Journal of General Practice 1995;45(399):542-7. 2835672
12. Lauritzen T, Nielsen KD, Leboeuf-Yde C, Lunde IM. The health project Ebeltoft: health check ups and discussions in general practice. Basic data from a 5-year, prospective, randomized, controlled population study. Ugeskrift for Laeger 1997;159(25):3940-6. 2835673
13. Rasmussen SR, Kilsmark J, Hvenegaard A, Thomsen JL, Engberg M, Lauritzen T, et al. [Forebyggende helbredsundersøgelser og helbredssamtaler i almen praksis. En sundhedsøkonomisk analyse af »Sundhedsprojekt Ebeltoft«]. Medicinsk Teknologivurdering - puljeprojekter; 6(6). Copenhagen (Denmark): Sundhedsstyrelsen, Center for Evaluering og Medicinsk Teknologivurdering 2006. 2835675
14. Rasmussen SR, Thomsen JL, Kilsmark J, Hvenegaard A, Engberg M, Lauritzen T, et al. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs. Scandinavian Journal of Public Health 2007;35(4):365-72. 2835676
15. Thomsen JL, Karlsmose B, Parner ET, Thulstrup AM, Lauritzen T, Engberg M. Secondary healthcare contacts after multiphasic preventive health screening: a randomized trial. Scandinavian Journal of Public Health 2006;34(3):254-61. 2835677
16. Thomsen JL, Parner ET. Methods for analysing recurrent events in health care data. Examples from admissions in Ebeltoft Health Promotion Project. Family Practice 2006;23(4):407-13. 2835679
17. Thomsen JL, Parner ET, Karlsmose B, Thulstrup AM, Lauritzen T, Engberg M. Effect of preventive health screening on long-term primary health care utilization. A randomized controlled trial. Family Practice 2005;22(3):242-8. 2835678
18. Davies G, Pyke S, Kinmonth AL, Family Heart Study Group. Effect of non-attenders on the potential of a primary care programme to reduce cardiovascular risk in the population. BMJ 1994;309(6968):1553-6. 2835681
19. Family Heart Study Group. British family heart study: its design and method, and prevalence of cardiovascular risk factors. The British Journal of General Practice 1994;44(397):62-7. 2835682
20. Family Heart Study Group. Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British Family Heart Study. BMJ 1994;308(6924):313-20. 2835683
21. Marteau TM, Kinmonth AL, Pyke S, Thompson SG, Family Heart Study Group. Readiness for lifestyle advice: self-assessments of coronary risk prior to screening in the British Family Heart Study. The British Journal of General Practice 1995;45(390):5-8. 2835684
22. Marteau TM, Kinmonth AL, Thompson S, Pyke S, British Family Heart Study Group. The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance?. The British Journal of General Practice 1996;46(411):577-82. 2835685
23. Pyke SD, Wood DA, Kinmonth AL, Thompson SG, Family Heart Study Group. Change in coronary risk and coronary risk factor levels in couples following lifestyle intervention. Archives of Family Medicine 1997;6(4):354-60. 2835686
24. Grimby G, Bjure J, Aurell M, Ekström-Jodal B, Tibblin G, Wilhelmsen L. Work capacity and physiologic responses to work. Men born in 1913. The American Journal of Cardiology 1972;30(1):37-42. 2835688
25. Larsson B, Björntorp P, Tibblin G. The health consequences of moderate obesity. International Journal of Obesity 1981;5(2):97-116. 2835689
26. Tibblin G. A population study of 50-year-old men. An analysis of the non-participation group. Acta Medica Scandinavica 1965;178(4):453-9. 2835692
27. Tibblin G. High blood pressure in men aged 50 -- a population study of men born in 1913. Acta Medica Scandinavica 1967;470:1-84. 2835693
28. Tibblin G, Aurell E, Hjortzberg-Nordlund H, Paulin S, Risholm L, Sanne H, et al. A general health examination of a random sample of 50-year-old men in Göteborg. Acta Medica Scandinavica 1965;177:739-49. 2835690
29. Tibblin G, Welin L, Larsson B, Ljungberg IL, Svärdsudd K. The influence of repeated health examinations on mortality in a prospective cohort study, with a comment on the autopsy frequency. The study of men born in 1913. Scandinavian Journal of Social Medicine 1982;10(1):27-32. 2835691
30. Wilhelmsen L, Berglund G, Elmfeldt D, Tibblin G, Wedel H, Pennert K, et al. The multifactor primary prevention trial in Göteborg, Sweden. European Heart Journal 1986;7(4):279-88. 2835695
31. Wilhelmsen L, Ljungberg S, Wedel H, Werkö L. A comparison between participants and non-participants in a primary preventive trial. Journal of Chronic Diseases 1976;29(5):331-9. 2835696
32. Wilhelmsen L, Tibblin G, Werkö L. A primary preventive study of Gothenburg, Sweden. Preventive Medicine 1972;1(1):153-60. 2835697
33. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation 2003;10(5):377-86. 9933736
34. Jørgensen T, Jacobsen RK, Toft U, Aadahl M, Glümer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;4(7):e004530. 9933737
35. Jørgensen T, Ladelund S, Borch-Johnsen K, Pisinger C, Schrader AM, Thomsen T, et al. Screening for risk of cardiovascular disease is not associated with mental distress: the Inter99 study. Preventive Medicine 2009;48(3):242-6. 9933738
36. Lau CJ, Pisinger C, Husemoen LL, Jacobsen RK, Linneberg A, Jørgensen T. Effect of general health screening and lifestyle counselling on incidence of diabetes in general population: Inter99 randomised trial. Preventive Medicine 2016;91:172-79. 9933739
37. Pisinger C, Ladelund S, Glümer C, Toft U, Aadahl M, Jørgensen T. Five years of lifestyle intervention improved self-reported mental and physical health in a general population: the Inter99 study. Preventive Medicine 2009;49(5):424-8. 2835701
38. Collen M. Cost analysis of the Kaiser Foundations systemized health evaluation. Preventive Medicine USA. New York: Prodist, 1976. 2835703
39. Collen MF. The cost-effectiveness of health checkups--an illustrative study. Western Journal of Medicine 1984;141(6):786-92. 2835705
40. Collen MF, Dales LG, Friedman GD, Flagle CD, Feldman R, Siegelaub AB. Multiphasic checkup evaluation study. 4. Preliminary cost benefit analysis for middle-aged men. Preventive Medicine 1973;2(2):236-46. 2835704
41. Cutler JL, Ramcharan S, Feldman R, Siegelaub AB, Campbell B, Friedman GD, et al. Multiphasic checkup evaluation study. 1. Methods and population. Preventive Medicine 1973;2(2):197-206. 2835706
42. Dales LG, Friedman GD, Collen MF. Evaluating periodic multiphasic health checkups: a controlled trial. Journal of Chronic Diseases 1979;32(5):385-404. 2835707
43. Dales LG, Friedman GD, Collen MF. Evaluation of a periodic multiphasic health checkup. Methods of Information in Medicine 1974;13(3):140-6. 2835708
44. Dales LG, Friedman GD, Ramcharan S, Siegelaub AB, Campbell BA, Feldman R, et al. Multiphasic Checkup Evaluation Study. 3. Outpatient clinic utilization, hospitalization, and mortality experience after seven years. Preventive Medicine 1973;2(2):221-35. 2835709
45. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. Journal of Chronic Diseases 1986;39(6):453-63. 2835710
46. Ramcharan S, Cutler JL, Feldman R, Siegelaub AB, Campbell B, Friedman GD, et al. Multiphasic checkup evaluation study. 2. Disabilty and chronic disease after seven years of multiphasic health checkups. Preventive Medicine 1973;2(2):207-20. 2835711
47. Selby JV, Friedman GD, Collen MF. Sigmoidoscopy and mortality from colorectal cancer: the Kaiser Permanente Multiphasic Evaluation Study. Journal of Clinical Epidemiology 1988;41(5):427-34. 2835712
48. Isacsson SO, Janzon L. Results of a quit-smoking research project in a randomly selected population. Scandinavian Journal of Social Medicine 1976;4(1):25-9. 2835714
49. Lannerstad O. Död och sjukdom bland medelålders män. Malmö: University of Lund, 1978. 2835716
50. Lannerstad O. Morbidity related to smoking and other risk factors. A population study of disability pension, hospital care and sickness benefit days among middle-aged men in Malmö, Sweden. Scandinavian Journal of Social Medicine 1980;8(1):25-31. 2835717
51. Lannerstad O, Sternby NH, Isacsson SO, Lindgren G, Lindell SE. Effects of a health screening on mortality and causes of death in middle-aged men. A prospective study from 1970 to 1974 of mean in Malmö, born 1914. Scandinavian Journal of Social Medicine 1977;5(3):137-40. 2835715
52. Murray DM, Luepker RV, Pirie PL, Grimm RH, Bloom E, Davis MA, et al. Systematic risk factor screening and education: a community-wide approach to prevention of coronary heart disease. Preventive Medicine 1986;15(6):661-72. 2835719
53. Fink R, Shapiro S, Rosenberg C. Social research problems in studies involving multiphasic health testing. Health Services Research 1972;7(4):314-21. 2835721
54. Shapiro S. Evaluation of two contrasting types of screening programs. Preventive Medicine 1973;2(2):266-77. 2835723
55. Shapiro S, Fink R, Rosenberg C. A program to measure the impact of multiphasic health testing on health differentials between poverty and non-poverty groups. Medical Care 1972;10(3):207-14. 2835722
56. Bennett AE, Fraser IG. Impact of a screening programme in general practice: a randomized controlled trial. International Journal of Epidemiology 1972;1(1):55-60. 2835725
57. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. BMJ 1995;310(6987):1099-104. 2835727
58. Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study after one year. BMJ 1994;308(6924):308-12. 2835728
59. Imperial Cancer Research Fund OXCHECK Study Group. Prevalence of risk factors for heart disease in OXCHECK trial: implications for screening in primary care. BMJ 1991;302(6784):1057-60. 2835729
60. Langham S, Thorogood M, Normand C, Muir J, Jones L, Fowler G. Costs and cost effectiveness of health checks conducted by nurses in primary care: the OXCHECK study. BMJ 1996;312(7041):1265-8. 2835730
61. O'Neill C. The OXCHECK Study: a nursing perspective. Oxford and Collaborators Health Check. Health Reports 1994;6(1):160-5. 2835731
62. Olsen DM, Kane RL, Proctor PH. A controlled trial of multiphasic screening. New England Journal of Medicine 1976;294(17):925-30. 2835733
63. D'Souza MF, Swan AV, Shannon DJ. A long-term controlled trial of screening for hypertension in general practice. Lancet 1976;1(7971):1228-31. 2835735
64. Eastwood MR, Trevelyan MH. Relationship between physical and psychiatric disorder. Psychological Medicine 1972;2(4):363-72. 2835736
65. South-East London Screening Study Group. A controlled trial of multiphasic screening in middle-age: results of the South-East London Screening Study. 1977. International Journal of Epidemiology 2001;30(5):935-40. 2835737
66. Stone DH, Crisp AH. The effect of multiphasic screening on aspects of psychiatric status in middle age: results of a controlled trial in general practice. International Journal of Epidemiology 1978;7(4):331-4. 2835738
67. Stone DH, D'Souza MF. Multiphasic screening in middle age: results and implications of a controlled trial in British general practice. Israel Journal of Medical Sciences 1981;17(2-3):215-21. 2835739
68. The South-East London Study Group. A controlled trial of multiphasic screening in middle-age: results of the South-East London screening study. International Journal of Epidemiology 1977;6(4):357-63. 2835740
69. Trevelyan H. Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine 1973;2(2):278-94. 2835741
70. Theobald H, Bygren LO, Carstensen J, Hauffman M, Engfeldt P. Effects of an assessment of needs for medical and social services on long-term mortality: a randomized controlled study. International Journal of Epidemiology 1998;27(2):194-8. 2835743
71. Thorner RM, Djordjevic D, Vuckmanovic C, Pesic B, Culafic B, Mark F. A study to evaluate the effectiveness of multiphasic screening in Yugoslavia. Preventive Medicine 1973;2(2):295-301. 2835745
72. Kornitzer M, Rose G. WHO European collaborative trial of multifactorial prevention of coronary heart disease. Preventive Medicine 1985;14(3):272-8. 2835747
73. Rose G. European collaborative trial of multifactorial prevention of coronary heart disease. Lancet 1987;1(8534):685. 2835748
74. World Health Organization European Collaborative Group. An international controlled trial in the multifactorial prevention of coronary heart disease. International Journal of Epidemiology 1974;3(3):219-24. 2835749
75. World Health Organization European Collaborative Group. European collaborative trial of multifactorial prevention of coronary heart disease: final report on the 6-year results. Lancet 1986;1(8486):869-72. 2835750
76. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 1. recruitment and initial findings. European Heart Journal 1980;1(1):73-80. 2835751
77. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 2. risk factor changes at two and four years. European Heart Journal 1982;3(2):184-90. 2835752
78. World Health Organization European Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. incidence and mortality results. European Heart Journal 1983;4(3):141-7. 2835753
79. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. Copenhagen (Denmark): World Health Organization 1989. 2835755
80. World Health Organization European Collaborative Group. WHO European collaborative trial in the multifactorial prevention of coronary heart disease. IARC Scientific Publications 1990;103:123-31. 2835754
81. ACTRN12610000511033. A randomised controlled trial on the effect of My Health Check, a new interactive web-based decision tool, on the adoption of health preventive behaviours in volunteers aged 30-69 years. www.anzctr.org.au (First received 31 January 2018). 9933741
82. Ajay VS, Tian M, Chen H, Wu Y, Li X, Dunzhu D, et al. A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale. BMC public health 2014;14:924. 9933743
83. Ayorinde AA, Porteous T, Sharma P. Screening for major diseases in community pharmacies: a systematic review. International Journal of Pharmacy Practice 2013;21:349-61. [DOI: https://dx.doi.org/10.1111/ijpp.12041]9933745
84. Baicker K, Taubman SL, Allen HL, Bernstein M, Gruber JH, Newhouse JP, et al. Oregon Health Study Group. The Oregon experiment - effects of medicaid on clinical outcomes. New England Journal of Medicine 2013;368:1713-22. [DOI: http://dx.doi.org/10.1056/NEJMsa1212321]9933747
85. Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ 2017;356:i6538. [DOI: http://dx.doi.org/10.1136/bmj.i6538]9933749
86. Bender AM, Kawachi I, Jørgensen T, Pisinger C. Neighborhood deprivation is strongly associated with participation in a population-based health check. PLoS ONE 2015;10(6):e0129819. [DOI: http://dx.doi.org/10.1371/journal.pone.0129819]9933751
87. Brett T, Arnold-Reed D, Phan C, Cadden F, Walker W, Manea-Walley W, et al. The Fremantle Primary PreventionStudy: a multicentre randomised trial of absolute cardiovascular risk reduction. British Journal of General Practice 2012;62(594):e22-8. 9933753
88. Caley M, Chohan P, Hooper J, Wright N. The impact of NHS Health Checks on the prevalence of disease in general practices: a controlled study. British Journal of General Practice 2014;64:e516-21. 9933755
89. Campbell-Scherer D, Rogers J, Manca D, Lang-Robertson K, Bell S, Salvalaggio G, et al. Guideline harmonization and implementation plan for the BETTER trial: building on existing tools to improve chronic disease prevention and screening in family practice. CMAJ Open 2014;2:E1-E10. [DOI: https://dx.doi.org/10.9778/cmajo.20130040]9933757
90. Carter P, Bodicoat DH, Davies MJ, Ashra NB, Riley D, Joshi N, et al. A retrospective evaluation of the NHS Health Check Programme in a multi-ethnic population. Journal of Public Health 2016;38:534-42. [DOI: 10.1093/pubmed/fdv115]9933759
91. Chang KC, Lee JT, Vamos EP, Soljak M, Johnston D, Khunti K, et al. Impact of the National Health Service Health Check on cardiovascular disease risk: a difference-in-differences matching analysis. CMAJ Open 2016;188:E228-38. [DOI: https://dx.doi.org/10.1503/cmaj.151201]9933761
92. Charles M, Simmons RK, Williams KM, Roglic G, Sharp SJ, Kinmonth AL, et al. Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort. British Journal of General Practice 2012;62:e396-e402. 9933763
93. Charles M, Fleischer J, Witte DR, Ejskjaer N, Borch-Johnsen K, Lauritzen T, et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia 2013;56:101-8. 9933765
94. Cochrane T, Davey R, Iqbal Z, Gidlow C, Kumar J, Chambers R, et al. NHS health checks through general practice: randomised trial of population cardiovascular risk reduction. BMC public health 2012;12:944. 9933767
95. Dalsgaard EM, Vestergaard M, Skriver MV, Maindal HT, Lauritzen T, Borch-Johnsen K, et al. Psychological distress, cardiovascular complications and mortality among people with screen-detected type 2 diabetes: follow-up of the ADDITION-Denmark trial. Diabetologia 2014;57:710-7. [DOI: https://dx.doi.org/10.1007/s00125-014-3165-4]9933769
96. Davis-Lameloise N, Hernan A, Janus ED, Stewart E, Carter R, Bennett CM, et al. Melbourne Diabetes Prevention Study (MDPS) research group. The Melbourne Diabetes Prevention Study (MDPS): study protocol for a randomized controlled trial. Trials 2013;14:31. [DOI: https://dx.doi.org/10.1186/1745-6215-14-31]9933771
97. Diederichsen AC, Rasmussen LM, Søgaard R, Lambrechtsen J, Steffensen FH, Frost L, et al. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial. Trials 2015;16:554. 9933773
98. Dirven JA, Tange HJ, Muris JW, Van Haaren KM, Vink G, Van Schayck OC. Early detection of COPD in general practice: patient or practice managed? A randomised controlled trial of two strategies in different socioeconomic environments. Primary Care Respiratory Journal 2013;22:331-7. [DOI: https://dx.doi.org/10.4104/pcrj.2013.00070]9933775
99. Doughty RN. Randomised controlled trial: community screening for heart failure: ready for prime time?. Evidence-Based Medicine 2014;19:107. [DOI: http://dx.doi.org/10.1136/eb-2013-101511]9933777
100. Duncan S, Goodyear-Smith F, McPhee J, Zinn C, Grøntved A, Schofield G. Family-centered brief intervention for reducing obesity and cardiovascular disease risk: a randomized controlled trial. Obesity (Silver Spring, Md.) 2016;24:2311-18. 9933779
101. Dyakova M, Shantikumar S, Colquitt JL, Drew CM, Sime M, MacIver J, et al. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2016, Issue 2. [DOI: 10.1002/14651858.CD010411.pub2]9933781
102. Echouffo-Tcheugui JB, Simmons RK, Prevost AT, Williams KM, Kinmonth AL, Wareham NJ, et al. Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior. Annals of Family Medicine 2015;13:149-57. 9933783
103. Engelsen C, Koekkoek PS, Godefrooij MB, Spigt MG, Rutten GE. Screening for increased cardiometabolic risk in primary care: a systematic review. British Journal of General Practice 2014;64(627):e616-e626. 9933785
104. Grunfeld E, Manca D, Moineddin R, Thorpe KE, Hoch JS, Campbell-Scherer D, et al. BETTER Trial Investigators. Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial. BMC Family Practice 2013;14:175. [DOI: https://dx.doi.org/10.1186/1471-2296-14-175]9933787
105. Haas J. Randomized trial of a personalized multi-condition risk assessment in primary care. International Journal for Quality in Health Care 2016;28 (Supplement 1):42-3. [DOI: http://dx.doi.org/10.1093/intqhc/mzw104.65]9933789
106. Haas JS, Baer HJ, Eibensteiner K, Klinger EV, St Hubert S, Getty G, et al. A cluster randomized trial of a personalized multi-condition risk assessment in primary care. American Journal of Preventive Medicine 2017;52:100-5. [DOI: http://dx.doi.org/10.1016/j.amepre.2016.07.013]9933791
107. Harris MF, Fanaian M, Jayasinghe UW, Passey ME, McKenzie SH, Powell Davies G, et al. A cluster randomised controlled trial of vascular risk factor management in general practice. Medical Journal of Australia 2012;197:387-93. 9933793
108. Harris MF, Parker SM, Litt J, Van Driel M, Russell G, Mazza D, et al. Preventive Evidence into Practice Partnership Group. An Australian general practice based strategy to improve chronic disease prevention, and its impact on patient reported outcomes: evaluation of the preventive evidence into practice cluster randomised controlled trial. BMC Health Services Research 2017;17:637. [DOI: https://dx.doi.org/10.1186/s12913-017-2586-4]9933795
109. Herman PM, Szczurko O, Cooley K, Seely D. A naturopathic approach to the prevention of cardiovascular disease: a cost effectiveness analysis of a randomized multi-worksite trial. BMC Complementary and Alternative Medicine. Conference: International Research Congress on Integrative Medicine and Health 2012;12 Suppl 1:O25. 9933797
110. Herman PM, Szczurko O, Cooley K, Seely D. A naturopathic approach to the prevention of cardiovascular disease: cost-effectiveness analysis of a pragmatic multi-worksite randomized clinical trial. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine 2014;56:171-6. 9933799
111. Herrigel DJ, Willett LR, Jørgensen T. 2014 - Intensive population-level screening and counseling did not reduce ischemic heart disease at 10 years. ACP Journal Club 2014;161:2. 9933801
112. Høj K, Skriver MV, Hansen AL, Christensen B, Maindal HT, Sandbæk A. Effect of including fitness testing in preventive health checks on cardiorespiratory fitness and motivation: study protocol of a randomized controlled trial. BMC public health 2014;14:1057. 9933803
113. Høj K, Vinther Skriver M, Terkildsen Maindal H, Christensen B, Sandbæk A. The effect of cardiorespiratory fitness assessment in preventive health checks: a randomised controlled trial. European Journal of Public Health 2018;28:173-9. [DOI: https://dx.doi.org/10.1093/eurpub/ckx108]9933805
114. Ijkema R, Aerde MA, Aalst CM, Ballegooijen M, Oudkerk M, Koning HJ. A randomized controlled trial measuring the effectiveness of screening for cardiovascular disease using classic risk assessment and coronary artery calcium: the ROBINSCA study. European Journal of Preventive Cardiology 2014;21:S21. 9933807
115. ISRCTN11833436. Impact evaluation of Oportunidades. www.isrctn.com (First received 31 January 2018). 9933809
116. Kaczorowski J, Chambers L, Dolovich L, Paterson JM, Karwalajtys T, Gierman T, et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011;342:d442. 9933811
117. Khetan AK, Purushothaman R, Chami T, Hejjaji V, Madan Mohan SK, Josephson RA, et al. The effectiveness of community health workers for CVD prevention in LMIC. Global Heart 2017;12:233-243.e6. [DOI: http://dx.doi.org/10.1016/j.gheart.2016.07.001]9933813
118. Kozela M, Szafraniec K, Broda G, Cichocka I, Drygas W, Gasior Z, et al. POLKARD Study Group. Detection and treatment of hypercholesterolemia in primary health care: results of the POLKARD program of the Ministry of Health of the Republic of Poland. Polskie Archiwum Medycyny Wewnetrznej 2012;122:154-61. 9933815
119. Lindholt JS, Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 2017;390:2256-65. 9933817
120. Lindsay P, Connor Gorber S, Joffres M, Birtwhistle R, McKay D, Cloutier L, Canadian Task Force on Preventive Health Care (CTFPHC). Recommendations on screening for high blood pressure in Canadian adults. Canadian Family Physician Medecin de Famille Canadien 2013;59:927-33, e393-400. 9933819
121. Del Mar C. Review: Primary care-based general health checks improve surrogate but not clinical outcomes. ACP Journal Club 2014;160:1-1. 9933821
122. McDermott L, Wright AJ, Cornelius V, Burgess C, Forster AS, Ashworth M, et al. Enhanced invitation methods and uptake of health checks in primary care: randomised controlled trial and cohort study using electronic health records. Health Technology Assessment 2016;20(84):1-92. 9933823
123. McKenzie SH, Jayasinghe UW, Fanaian M, Passey M, Harris MF. Analysis of the psychological impact of a vascular risk factor intervention: results from a cluster randomized controlled trial in Australian general practice. BMC Family Practice 2013;14:190. 9933825
124. NCT02224248. Effect of including fitness testing in preventive health checks on cardiorespiratory fitness and motivation. www.clinicaltrials.gov (First received 31 January 2018). 9933827
125. NCT02615769. Effect on attendance if including focused information of spirometry in preventive health checks. www.clinicaltrials.gov (First received 31 January 2018). 9933829
126. NTR2379. The effectiveness of health check-ups for promoting healthy behavior: a quasi-experimental study. www.trialregister.nl (First received 31 January 2018). 9933831
127. Oldenburg B, Sathish T, Thankappan KR, Balachandran S, D'Esposito F, Mathews E, et al. Identifying people at high risk for type 2 diabetes: preliminary results from the Kerala Diabetes Prevention Programme. Diabetologia 2015;58:S166. 9933833
128. Ørts LM, Løkke A, Bjerregaard AL, Maindal HT, Sandbæk A. Effect on attendance by including focused information on spirometry in preventive health checks: study protocol for a randomized controlled trial. Trials 2016;17(1):571. 9933835
129. Panniyammakal P, Harikrihnan S, Prabhakaran D. A PROgramme of lifestyle Intervention in families for cardiovascular risk reduction (PROLIFIC Study): design and rationale of a family based randomized controlled trial. European Journal of Preventive Cardiology. Conference: Europrevent 2017. Spain 2017;24:S27. 9933837
130. Paszat L, Sutradhar R, O'Brien MA, Lofters A, Pinto A, Selby P, et al. BETTER HEALTH: Durham -- protocol for a cluster randomized trial of BETTER in community and public health settings. BMC Public Health 2017;17:754. [DOI: https://dx.doi.org/10.1186/s12889-017-4797-3]9933839
131. Rodondi N, Auer R, de Bosset Sulzer V, Ghali WA, Cornuz J. Atherosclerosis screening by noninvasive imaging for cardiovascular prevention: a systematic review. Journal of General Internal Medicine 2012;27:220-31. [DOI: http://dx.doi.org/10.1007/s11606-011-1833-3]9933841
132. Si S, Moss JR, Sullivan TR, Newton SS, Stocks NP. Effectiveness of general practice-based health checks: a systematic review and meta-analysis. British Journal of General Practice 2014;64:e47-e53. [DOI: http://dx.doi.org/10.3399/bjgp14X676456]9933843
133. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 2012;380:1741-8. 9933845
134. Simmons RK, Griffin SJ, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbæk A. Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1, 912, 392 Danish adults. Diabetologia 2017;60(11):2183-91. 9933847
135. Stickler GB. Are yearly physical examinations in adolescents necessary?. Journal of the American Board of Family Practice 2000;13(3):172-7. 9933849
136. Yan LL, Fang W, Delong E, Yao C, Neal B, Peterson ED, et al. China rural health initiative - primary care provider study: a large cluster-randomized controlled trial of high cardiovascular risk management in rural China. Circulation 2013;128:2715-16. 9933851
137. Maindal HT, Støvring H, Sandbaek A. Effectiveness of the population-based Check Your Health preventive programme conducted in primary care with 4 years follow-up [the COREtrial]: study protocol for a randomised controlled trial. Trials 2014;15:341. 9933853
138. NCT01979107. Early detection of and intervention towards chronic diseases among individuals without formal education. www.clinicaltrials.gov (First received 31 January 2018). 9933855
139. Barger SD, Muldoon MF. Hypertension labelling was associated with poorer self-rated health in the Third US National Health and Nutrition Examination Survey. Journal of Human Hypertension 2006;20(2):117-23. [PUBMED: 16267563]
140. Ben-Shlomo Y, Smith GD, Shipley MJ, Marmot MG. What determines mortality risk in male former cigarette smokers?. American Journal of Public Health 1994;84(8):1235-42.
141. Bender AM, Jørgensen T, Pisinger C. Is self-selection the main driver of positive interpretations of general health checks? The Inter99 randomized trial. Preventive Medicine 2015;81:42-8.
142. Beswick AD, Rees K, Dieppe P, Ayis S, Gooberman-Hill R, Horwood J, et al. Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis. Lancet 2008;371(9614):725-35.
143. Bloom JR, Monterossa S. Hypertension labeling and sense of well-being. American Journal of Public Health 1981;71(11):1228-32.
144. Boulware LE, Marinopoulos S, Phillips KA, Hwang CW, Maynor K, Merenstein D, et al. Systematic review: the value of the periodic health evaluation. Annals of Internal Medicine 2007;146(4):289-300.
145. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Annals of Internal Medicine 2007;146(7):502-10. [PUBMED: 17404352]
146. Collins RE, Lopez LM, Marteau TM. Emotional impact of screening: a systematic review and meta-analysis. BMC Public Health 2011;11:603.
147. Cook DG, Shaper AG, Pocock SJ, Kussick SJ. Giving up smoking and the risk of heart attacks. Lancet 1986;2(8520):1376-80.
148. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple risk factor interventions for primary prevention of coronary heart disease. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD001561.pub3]
149. Engberg M, Christensen B, Karlsmose B, Lauritzen T. Re: Should general health surveys be offered to the population?. Ugeskrift for Laeger 2002;164(36):4200-1.
150. US Food, Drug Administration. Full-body CT scans - what you need to know. www.fda.gov/Radiation-EmittingProducts/RadiationEmittingProductsandProcedures/MedicalImaging/MedicalX-Rays/ucm115340.htm (accessed 22 March 2018).
151. Fleming TR, DeMets DL. Surrogate end points in clinical trials - are we being misled?. Annals of Internal Medicine 1996;125(7):605-13.
152. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. Journal of Chronic Diseases 1986;39(6):453-63.
153. Furtado CD, Aguirre DA, Sirlin CB, Dang D, Stamato SK, Lee P, et al. Whole-body CT screening: spectrum of findings and recommendations in 1192 patients. Radiology 2005;237(2):385-94.
154. Golomb BA, Evans MA, Dimsdale JE, White HL. Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Archives of Internal Medicine 2012;172(15):1180-2.
155. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version Accessed 20 January 2019. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
156. Grønhøj Larsen C, Jørgensen KJ, Gøtzsche PC. Regular health checks: cross sectional survey. PloS One 2012;7(3):e33694.
157. Hamer M, Batty GD, Stamatakis E, Kivimaki M. Hypertension awareness and psychological distress. Hypertension 2010;56:547-50.
158. Han PK. Historical changes in the objectives of the periodic health examination. Annals of Internal Medicine 1997;127(10):910-7.
159. Haynes RB, Sackett DL, Taylor DW, Gibson ES, Johnson AL. Increased absenteeism from work after detection and labelling of hypertensive patients. New England Journal of Medicine 1978;299(14):741-4. [PUBMED: 692548]
160. Healy D. Let Them Eat Prozac. New York and London: New York University Press, 2004.
161. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
162. Higgins JP, Altman DG, Sterne JA (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017. Available from www.training.cochrane.org/handbook.
163. Holland WW. Periodic health examination - a brief history and critical assessment. Eurohealth 2009;15(4):16-20.
164. Holme Ø, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database of Systematic Reviews 2013, Issue 9. [DOI: 10.1002/14651858.CD009259.pub2]
165. Hooper L, Summerbell CD, Thompson R, Sills D, Roberts FG, Moore H, et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews 2012, Issue 5. [DOI: 10.1002/14651858.CD002137.pub3]
166. Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews 2015, Issue 6. [DOI: 10.1002/14651858.CD011737]
167. Ilic D, Neuberger M, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD004720.pub3]
168. Jørgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glümer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. European Journal of Cardiovascular Prevention and Rehabilitation 2003;10(5):377-86.
169. Jørgensen AW, Lundstrøm LH, Wetterslev J, Astrup A, Gøtzsche PC. Comparison of results from different imputation techniques for missing data from an anti-obesity drug trial. PLoS One 2014;9(11):e111964.
170. Karmali KN, Persell SD, Perel P, Lloyd-Jones DM, Berendsen MA, Huffman MD. Risk scoring for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2017, Issue 3. [DOI: 10.1002/14651858.CD006887.pub4]
171. Lauritzen T. [Helbredsundersøgelser og samtaler reducerer deltagernes risikoscore for hjerte-kar-sygdom]. Månedsskrift for Almen Praksis 2012;90(3):245-50.
172. Lehman R, Yudkin JS, Krumholz H. Licensing drugs for diabetes. BMJ 2010;341:c4805.
173. Martin RM, Donovan JL, Turner EL, Metcalfe C, Young GJ, Walsh EI, et al. Effect of a low-intensity PSA-based screening interventionon prostate cancer mortality: the CAP randomized clinical trial. JAMA 2018;319(9):883-95.
174. Nakao Y, Miyamoto Y, Ueshima K, Nakao K, Nakai M, Nishimura K, et al. Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: the metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study). PLoS One 2018;13(1):e0190862.
175. Nissen SE, Wolski K. Rosiglitazone revisited. An updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Archives of Internal Medicine 2010;170(14):1191-201.
176. Patrick DL, Grembowski D, Durham M, Beresford SA, Diehr P, Ehreth J, et al. Cost and outcomes of Medicare reimbursement for HMO preventive services. Health Care Financing Review 1999;20(4):25-43.
177. Pill R, French J, Harding K, Stott N. Invitation to attend a health check in a general practice setting: comparison of attenders and non-attenders. Journal of the Royal College of General Practitioners 1988;38(307):53-6.
178. Piper M, Evans CV, Burda BU, Margolis KL, O'Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2015;162(3):192-204.
179. Pisinger C, Ladelund S, Glümer C, Toft U, Aadahl M, Jørgensen T. Five years of lifestyle intervention improved self-reported mental and physical health in a general population: the Inter99 study. Preventive Medicine 2009;49(5):424-8.
180. Raffle A, Gray M. Screening: Evidence and Practice. New York: Oxford University Press, 2007.
181. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
182. Robson J, Dostal I, Sheikh A, Eldridge S, Madurasinghe V, Griffiths C, et al. The NHS Health Check in England: an evaluation of the first 4 years. BMJ Open 2016;6(1):e008840.
183. Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Akl E, et al. on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Completing 'Summary of findings' tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook.
184. Selph S, Dana T, Blazina I, Bougatsos C, Patel H, Chou R. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Annals of Internal Medicine 2015;162(11):765-76.
185. Shaw C, Abrams K, Marteau TM. Psychological impact of predicting individuals' risks of illness: a systematic review. Social Science & Medicine 1999;49(12):1571-98.
186. Sheridan S, Pignone M, Donahue K. Screening for high blood pressure: a review of the evidence for the U.S. Preventive Services Task Force. American Journal of Preventive Medicine 2003;25(2):151-8. [PUBMED: 12880884]
187. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Services Research 2008;8:60. [DOI: 10.1186/1472-6963-8-60]
188. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006;333(7557):15.
189. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 5. [DOI: 10.1002/14651858.CD000165.pub4]
190. Taylor F, Huffman MD, Macedo AF, Moore THM, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2013, Issue 1. [DOI: 10.1002/14651858.CD004816.pub5]
191. Trevelyan H. Study to evaluate the effects of multiphasic screening within general practice in Britain: design and method. Preventive Medicine 1973;2(2):278-94.
192. Uijen AA, Bakx JC, Mokkink HG, Van Weel C. Hypertension patients participating in trials differ in many aspects from patients treated in general practices. Journal of Clinical Epidemiology 2007;60(4):330-5.
193. UK National Screening Committee. Programme appraisal criteria. www.screening.nhs.uk/criteria (accessed 3 August 2012).
194. Waller D, Agass M, Mant D, Coulter A, Fuller A, Jones L. Health checks in general practice: another example of inverse care?. BMJ 1990;300(6732):1115-8.
195. Walter LC, Fung KZ, Kirby KA, Shi Y, Espaldon R, O'Brien S, et al. Five-year downstream outcomes following prostate-specific antigen screening in older men. JAMA Internal Medicine 2013;173(10):866-73.
196. Welch HG. Should I be tested for cancer? Maybe not and here's why. Berkeley: University of California Press, 2004.
197. Welch HG, Schwartz LM, Woloshin S. Overdiagnosed - Making people sick in the pursuit of health. Boston: Beacon Press, 2011.
198. Oliver MF, Heady JA, Morris JN, Cooper J, on behalf of the Committee of Principal Investigators. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators. Lancet 1984;2(8403):600-4.
199. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2]
200. Xiong T, Richardson M, Woodroffe R, Halligan S, Morton D, Lilford RJ. Incidental lesions found on CT colonography: their nature and frequency. The British Journal of Radiology 2005;78(925):22-9.
201. Krogsbøll LT, Jørgensen KJ, Gøtzsche PC. General health checks for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews 2011, Issue 2. [DOI: 10.1002/14651858.CD009009]
202. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD009009.pub2]